Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aptus Pharma Ltd has informed BSE that its Board of Directors meeting is scheduled for April 27, 2026 to consider and approve the audited financial results for the half year/year ended March 31, 2026 and to take on record the Auditor Report. The company has also announced the closure of its Trading Window for insiders, which will remain closed until 48 hours after the financial results are declared. This is a routine regulatory intimation filed under SEBI Listing Regulations. No financial figures or performance details are disclosed in this filing.
This is a standard pre-result announcement filing with no material impact on shareholders at this stage. Investors should note the upcoming results date and the trading window closure period when insider trading restrictions apply.